MSX1 and breast carcinoma: In earlier studies, aberrant methylation of MSX1 promoter DNA has been linked to lung cancer, gastric cancer, Wilms tumor, childhood acute T-lymphoblastic leukemia, and breast cancer [21,22,23,24,25].